Aberrant B cell expansion and survival contribute to B cell malignancies, such as multiple myeloma, diffuse large B cell lymphoma, and chronic lymphocytic leukemia, which are frequently associated with TRAF3 gene deletions or inactivating mutations (114–116). The gene discussed is TRAF3; the disease is plasma cell myeloma.